IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — SYRE

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.160.100.060.080.050.070.050.230.090.240.040.040.040.010.020.030.08
Accounts Receivable--------------------------------0.02
Total Current Assets1.170.760.500.540.570.420.440.490.210.240.040.080.100.070.120.130.15
Property, Plant & Equipment----------------0.000.000.000.000.000.000.000.010.01
Total Non-current Assets*0.000.000.000.000.000.000.000.000.000.000.010.010.010.010.010.010.01
Total Assets1.170.760.500.540.570.420.440.490.210.240.050.090.110.080.130.150.16
Accounts Payable------------------0.000.000.000.000.000.000.000.00
Total Current Liabilities0.060.090.050.080.070.060.020.040.040.230.010.020.020.020.020.020.03
Total Non-current Liabilities*0.010.010.000.000.020.040.040.040.020.020.010.010.010.010.010.010.01
Total Liabilities0.070.090.050.080.090.090.060.080.070.250.020.020.020.020.030.030.04
Retained Earnings(1.23)(1.20)(1.07)(1.05)(1.02)(0.92)(0.85)(0.81)(0.70)(0.66)(0.44)(0.41)(0.39)(0.37)(0.32)(0.30)(0.29)
Total Stockholder Equity1.100.670.460.460.480.330.370.15(0.25)(0.21)0.030.070.080.060.100.120.12

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue------------0.000.000.000.000.000.000.690.200.170.170.631.363.641.40
Research & Development--------------------------13.7814.2511.9815.3716.9816.7814.85
Selling, General & Admin16.1415.2312.5311.6411.7911.9410.7710.6511.5112.8514.078.5812.065.235.086.957.688.827.306.84
Total Operating Expenses41.6445.6457.1756.8941.9453.5761.2555.3944.1547.7745.9118.34159.9319.0019.3318.9323.0525.8024.0921.69
Operating Income(41.64)(45.64)(57.17)(56.89)(41.93)(53.57)(61.25)(55.39)(44.15)(47.77)(45.91)(18.34)(159.25)(18.81)(19.16)(18.75)(22.42)(24.44)(20.44)(20.29)
Pretax Income(36.20)(69.00)(62.53)(11.18)(36.72)(44.79)(56.29)(69.01)(38.84)(43.82)(63.18)(40.10)(217.07)(18.46)(18.78)(18.44)(22.31)--(20.42)(20.28)
Tax Provision0.000.000.000.000.00(0.01)0.000.020.000.030.000.000.01(0.04)0.04(0.21)0.01--0.020.03
Net Income(36.20)(69.00)(62.53)(11.18)(36.72)(44.77)(56.30)(69.03)(38.84)(43.86)(63.18)(40.11)(217.08)(18.42)(18.82)(18.23)(22.32)(24.44)(20.45)(20.31)
Basic EPS--------------1.060.590.72(37.31)(9.34)(2.27)(0.20)(0.18)(0.19)(0.27)------
Diluted EPS(1.09)(0.74)--(0.15)(1.09)----1.060.590.72(37.31)(9.34)(2.27)(0.20)(0.18)(0.19)(0.27)------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(69.88)(57.37)(44.58)(37.12)(46.56)(40.99)(37.20)(29.42)(62.25)(28.54)(31.04)(34.60)(16.64)(17.63)(18.14)(15.07)(20.67)(26.26)(19.27)(17.00)
Capital Expenditures--------------------0.000.00----0.000.000.000.040.000.09
Free Cash Flow*--------------------(31.04)(34.60)----(18.14)(15.07)(20.67)(26.30)(19.27)(17.09)
Investing Cash Flow(297.90)56.58(247.41)25.0079.00(0.06)(170.54)42.74(120.52)(104.96)(35.27)(97.63)6.7617.7514.0016.500.7525.769.665.78
Financing Cash Flow432.6012.26312.81(4.64)0.730.13225.6012.780.36172.17163.61(12.53)209.990.01(0.01)(0.13)42.800.010.081.14

* Derived from reported values